Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett

Showing results (171-180 of 330) with videos related to

Pageof 33
Sort By:
Plastic Surgery (Oakville, Ont.)|May 12, 2025
Health Inequities in the Epidemiology, Diagnosis, Treatment, and Outcomes of Plastic Surgery: A Scoping ReviewTy Moore, Danya Nees, Samuel Jacobsen, et al.
Japanese Journal of Radiology|June 30, 2010
Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomesJohn M Watkins, John A Fortney, Amy E Wahlquist, et al.
Journal for Immunotherapy of Cancer|March 22, 2025
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapyThomas U Marron, Jason J Luke, Brianna Hoffner, et al.
Journal of Medical Imaging and Radiation Oncology|October 21, 2010
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survivalJohn M Watkins, Amy E Wahlquist, A Jason Zauls, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancerColin D Weekes, Dongweon Song, John Arcaroli, et al.
JCO Oncology Practice|March 11, 2021
Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ ObservationsAsh B Alpert, George A Komatsoulis, Stephen C Meersman, et al.
Journal of Cancer Survivorship : Research and Practice|June 27, 2022
A pilot randomized controlled trial to evaluate a survivorship care planning intervention for head and neck cancer survivor-caregiver dyadsKatherine R Sterba, Kent Armeson, Jane Zapka, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2017
Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosisDaniel J Neitzke, Jacob S Bowers, Kristina Andrijauskaite, et al.
JCO Oncology Practice|October 7, 2025
Where Have We Been and Where Are We Going? The State of the Hematology and Medical Oncologist Workforce in AmericaM Kelsey Kirkwood, Erin P Balogh, Melissa K Accordino, et al.
Head & Neck|January 22, 2009
Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancersJohn M Watkins, Keisuke S Shirai, Amy E Wahlquist, et al.
Pageof 33

Showing results (171-180 of 330) with videos related to

Sort By:
Pageof 33
Plastic Surgery (Oakville, Ont.)|May 12, 2025
Health Inequities in the Epidemiology, Diagnosis, Treatment, and Outcomes of Plastic Surgery: A Scoping ReviewTy Moore, Danya Nees, Samuel Jacobsen, et al.
Japanese Journal of Radiology|June 30, 2010
Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomesJohn M Watkins, John A Fortney, Amy E Wahlquist, et al.
Journal for Immunotherapy of Cancer|March 22, 2025
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapyThomas U Marron, Jason J Luke, Brianna Hoffner, et al.
Journal of Medical Imaging and Radiation Oncology|October 21, 2010
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survivalJohn M Watkins, Amy E Wahlquist, A Jason Zauls, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancerColin D Weekes, Dongweon Song, John Arcaroli, et al.
JCO Oncology Practice|March 11, 2021
Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ ObservationsAsh B Alpert, George A Komatsoulis, Stephen C Meersman, et al.
Journal of Cancer Survivorship : Research and Practice|June 27, 2022
A pilot randomized controlled trial to evaluate a survivorship care planning intervention for head and neck cancer survivor-caregiver dyadsKatherine R Sterba, Kent Armeson, Jane Zapka, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2017
Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosisDaniel J Neitzke, Jacob S Bowers, Kristina Andrijauskaite, et al.
JCO Oncology Practice|October 7, 2025
Where Have We Been and Where Are We Going? The State of the Hematology and Medical Oncologist Workforce in AmericaM Kelsey Kirkwood, Erin P Balogh, Melissa K Accordino, et al.
Head & Neck|January 22, 2009
Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancersJohn M Watkins, Keisuke S Shirai, Amy E Wahlquist, et al.
Pageof 33